146 related articles for article (PubMed ID: 3502167)
1. Immunomodulatory and therapeutic properties of alkyl lysophospholipids in mice.
Talmadge JE; Schneider M; Lenz B; Phillips H; Long C
Lipids; 1987 Nov; 22(11):871-7. PubMed ID: 3502167
[TBL] [Abstract][Full Text] [Related]
2. Modulation of chemical carcinogenesis in rats by alkyl lysophospholipids.
Berger MR; Schmähl D
Lipids; 1987 Nov; 22(11):935-42. PubMed ID: 3127647
[TBL] [Abstract][Full Text] [Related]
3. Increased membrane permeability for an antitumoral alkyl lysophospholipid in sensitive tumor cells.
Storch J; Munder PG
Lipids; 1987 Nov; 22(11):813-9. PubMed ID: 3444371
[TBL] [Abstract][Full Text] [Related]
4. Activation of peritoneal macrophages by orally administered ether analogues of lysophospholipids.
Ngwenya BZ; Fiavey NP; Mogashoa MM
Proc Soc Exp Biol Med; 1991 May; 197(1):91-7. PubMed ID: 1850526
[TBL] [Abstract][Full Text] [Related]
5. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
Vogler WR; Olson AC; Berdel WE; Okamoto S; Glasser L
Prog Clin Biol Res; 1990; 333():1-18; discussion 19-20. PubMed ID: 2308973
[TBL] [Abstract][Full Text] [Related]
6. Activation of macrophages by ether analogues of lysophospholipids.
Yamamoto N; Ngwenya BZ; Sery TW; Pieringer RA
Cancer Immunol Immunother; 1987; 25(3):185-92. PubMed ID: 2824051
[TBL] [Abstract][Full Text] [Related]
7. Antineoplastic activity of conjugates of lipids and 1-beta-D-arabinofuranosylcytosine.
Berdel WE; Danhauser S; Schick HD; Hong CI; West CR; Fromm M; Fink U; Reichert A; Rastetter J
Lipids; 1987 Nov; 22(11):943-6. PubMed ID: 3444389
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
Unger C; Eibl H; Kim DJ; Fleer EA; Kötting J; Bartsch HH; Nagel GA; Pfizenmaier K
J Natl Cancer Inst; 1987 Feb; 78(2):219-22. PubMed ID: 3468284
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylcholine attenuates the cytotoxic effects of the antineoplastic phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3- phosphocholine.
Boggs KP; Rock CO; Jackowski S
J Biol Chem; 1995 May; 270(19):11612-8. PubMed ID: 7744800
[TBL] [Abstract][Full Text] [Related]
10. Noncytotoxic alkyl-lysophospholipid treatment increases sensitivity of leukemic K562 cells to lysis by natural killer (NK) cells.
Botzler C; Kolb HJ; Issels RD; Multhoff G
Int J Cancer; 1996 Mar; 65(5):633-8. PubMed ID: 8598315
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor action of alkyl-lysophospholipids (Review).
Berdel WE; Bausert WR; Fink U; Rastetter J; Munder PG
Anticancer Res; 1981; 1(6):345-52. PubMed ID: 7046622
[TBL] [Abstract][Full Text] [Related]
12. Structure-cytotoxicity studies on alkyl lysophospholipids and some analogs in leukemic blasts of human origin in vitro.
Danhauser S; Berdel WE; Schick HD; Fromm M; Reichert A; Fink U; Busch R; Eibl H; Rastetter J
Lipids; 1987 Nov; 22(11):911-5. PubMed ID: 3444384
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of synthetic alkylphospholipids with or without PAF activity.
Kudo I; Nojima S; Chang HW; Yanoshita R; Hayashi H; Kondo E; Nomura H; Inoue K
Lipids; 1987 Nov; 22(11):862-7. PubMed ID: 3444379
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of ether lipids on the activity and secretion of interleukin-1 and interleukin-2.
Andreesen R; Giese V
Lipids; 1987 Nov; 22(11):836-41. PubMed ID: 3502166
[TBL] [Abstract][Full Text] [Related]
15. Enhanced therapeutic effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.
Ahmad I; Filep JJ; Franklin JC; Janoff AS; Masters GR; Pattassery J; Peters A; Schupsky JJ; Zha Y; Mayhew E
Cancer Res; 1997 May; 57(10):1915-21. PubMed ID: 9157985
[TBL] [Abstract][Full Text] [Related]
16. Cyclic oxygen analogues of alkyl-lysophospholipids. Synthesis and neoplastic cell growth inhibitory properties.
Houlihan WJ; Lee ML; Munder PG; Winslow CM; Cheon SH; D'Aries FJ; DeLillo AK; Jaeggi CS; Mason RB; Parrino VA
J Lipid Mediat; 1990; 2(5):295-307. PubMed ID: 2133273
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice.
Talmadge JE; Tribble HR; Pennington RW; Phillips H; Wiltrout RH
Cancer Res; 1987 May; 47(10):2563-70. PubMed ID: 3105865
[TBL] [Abstract][Full Text] [Related]
18. Anti-neoplastic action of peritoneal macrophages following oral administration of ether analogues of lysophospholipids.
Ngwenya BZ; Fiavey NP; Mogashoa MM
Eur J Cancer; 1992; 28A(10):1637-42. PubMed ID: 1389479
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of T lymphocytes in vitro by syngeneic macrophages fed with tumor antigens.
Treves AJ; Schechter B; Cohen IR; Feldman M
J Immunol; 1976 Apr; 116(4):1059-64. PubMed ID: 1082902
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of alkyl chain-modified ether lipids and evaluation of their in vitro cytotoxicity.
Fos E; Suesa N; Borras L; Lobato C; Banfi P; Gambetta RA; Zunino F; Mauleón D; Carganico G
J Med Chem; 1995 Mar; 38(7):1216-28. PubMed ID: 7707324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
